Dr. Mark J. Alberts of the UT Southwestern Medical Center sees biotech company Pozen‘s PA32540 as a viable, GI-safer form of aspirin treatment.
http://www.swbiosearch.com/2013/02/11/ut-southwestern-medical-center-sees-promise-in-pozen-aspirin-alternative/
No comments:
Post a Comment